Immune Complex Corporation
Business Identifier: NO Business Identifier is currently available for this company.
Public Profile:
Immune Complex Corporation manufactures and markets custom synthetic oligonucleotides used in detecting the presence of specific DNA sequences. The firm developed a vaccine delivery system based upon the Hepatitis- B core protein.In September1997 BioQuest, Inc. (NASDAQ: HIVX) acquired Immune Complex Corporation in a stock and cash deal.

 Synopsis: Awardee Business Condition
Year Founded IP Holdings
Employee Range VC funded?
Revenue Range Private/Public
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
Malaria Vaccine
Bioreactor Synthesis Of Cytochrome P450 Metabolites
High Throughout Colormetric Genotyping
Therapeutic Treatment For Chronic Human Renal Rejection
Human P45OS - high level expression and immunoreagents